European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 3.720
+0.020 (0.54%)
Aug 11, 2026, 9:00 AM CET
EBR:ALEMS Market Cap
EBR:ALEMS has a market cap or net worth of €15.66 million as of August 11, 2026. Its market cap has decreased by -19.57% in one year.
Market Cap
15.66M
Enterprise Value
29.45M
Revenue
52.80M
Ranking
n/a
PE Ratio
8.51
Stock Price
€3.72
ChartMarket Cap Chart
Since May 11, 2016, EBR:ALEMS's market cap has decreased from 86.09M to 15.66M, a decrease of -81.81%. That is a compound annual growth rate of -15.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 17.01M | -22.69% |
| Dec 31, 2025 | 22.01M | -13.33% |
| Dec 31, 2024 | 25.39M | -27.47% |
| Dec 29, 2023 | 35.01M | -57.73% |
| Dec 30, 2022 | 82.82M | 1,588.91% |
| Dec 31, 2021 | 4.90M | 0.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.73B |
| UCB SA | 42.54B |
| Financière de Tubize | 8.48B |
| Onward Medical | 165.48M |
| Hyloris Pharmaceuticals | 127.68M |
| Celyad Oncology | 12.09M |
| BioSenic | 1.31M |
| Oxurion NV | 248.34K |